Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program to Support Research on New Virus Strains January 14, 2021January 14, 2021 by / Share This.....LinkedinTwitterFacebookGoogleEmailSubsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations Related News: Thermo Fisher Scientific Launches Ion AmpliSeq…PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2…Thermo Fisher Scientific Announces Oncomine Clinical…Oxford Nanopore provides updated kits and protocols…PacBio Launches HiFiViral SARS-CoV-2 Kit and…Thermo Fisher Scientific Extends the Expiration of…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
